David Schenkein - Director at Agios Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AGIO on Nasdaq
All Insider Reports
All Insider Reports

David Schenkein - trading volume in the past year for Agios Pharmaceuticals, Inc.

Holdings reported by David Schenkein for Agios Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 126K $6.17M $48.84 Jun 13, 2024 Direct
Common stock 79.1K $3.86M $48.84 Jun 13, 2024 Indirect
Restricted stock units 2.12K $104K $48.84 Jun 20, 2024 Direct Common stock
Stock options (right to buy) 11.8K Jun 20, 2024 Direct Common stock

Transactions reported by David Schenkein for Agios Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.